Synlett 2018; 29(09): 1125-1130
DOI: 10.1055/s-0036-1591776
synpacts
© Georg Thieme Verlag Stuttgart · New York

The Synthesis of (–)-Spiroleucettadine

Richard A. Lamb
a   Department of Chemistry, University of Otago, PO Box 56, Dunedin 9054, New Zealand   Email: bhawkins@chemistry.otago.ac.nz
,
Guillaume Lessene*
b   The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia   and Department of Medical Biology and Department of Pharmacology and Therapeutics, The University of Melbourne, Parkville, Victoria 3050, Australia   Email: glessene@wehi.edu.au
,
a   Department of Chemistry, University of Otago, PO Box 56, Dunedin 9054, New Zealand   Email: bhawkins@chemistry.otago.ac.nz
› Author Affiliations
Support for this research from the NHMRC (fellowship for G.L. GNT1117089), from the Australian Cancer Research Foundation, the Victorian State Government Operational Infrastructure Support, and Australian Government NHMRC IRIISS is gratefully acknowledged.
Further Information

Publication History

Received: 04 February 2018

Accepted after revision: 19 February 2018

Publication Date:
05 March 2018 (online)


Abstract

The interesting history of (–)-spiroleucettadine, a marine natural product, is discussed along with some of our original unsuccessful synthetic strategies. Finally, we briefly discuss our reported enantiospecific synthesis of spiroleucettadine, and how we plan to use this as a platform for further studies around this interesting class of molecules.